Concepedia

D S Goldstein

DS

7

Publications

399

Citations

7

H-Index

1986

Active since

Affiliations

University of California Davis Medical Center(Current)

University of California, Davis

D S Goldstein is an author at University of California Davis Medical Center specializing in medicine, oncology, and immunotherapy.

Top concepts

Publications per year

1986–2001

7

Publications

7

Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma.

Gerald L. DeNardo, Sally J. DeNardo, D S Goldstein et al. · Journal of Clinical Oncology · 1998 · 182 citations

Radioimmunotherapy for advanced breast cancer using I-131-ChL6 antibody.

Sally J. DeNardo, L.F. O'Grady, Carol M. Richman et al. · PubMed · 1997 · 60 citations

Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer.

Robert T. OʼDonnell, Sally J. DeNardo, A. Yuan et al. · PubMed · 2001 · 56 citations

Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin A.

Carol M. Richman, Sally J. DeNardo, Robert T. OʼDonnell et al. · PubMed · 1999 · 37 citations

, , +13

67Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl-TETA-Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma.

Robert T. OʼDonnell, Gerald L. DeNardo, David L. Kukis et al. · PubMed · 1999 · 28 citations

, , +11

Rows per page

1–5 of 7